TNS1 and neoplasm: Since the focal adhesion targeting sites in DLC1 overlap with the tensin protein binding site, it has been accepted that DLC1 couples with tensin and functions as tumor suppressive complex in terminating the focal adhesion-associated Rho activity [10], [14], [15].